News and Trends 4 Nov 2017 Bioart from the Ocean Depths: Underwater Sounds …are still songs to sing beyond mankind.” https://vimeo.com/126787314 Upcoming events by Robertina Šebjanič Performance: Aquatocene / Subaquatic quest for serenity Tesla Award at City Museum Ljubljana, Slovenia 8 November Exhibition:… November 4, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 18 Feb 2025 T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments …can be stopped at any time, thereby reversing immune activation and immune-related adverse events,” the paper stated. So, even though both kinds of therapy can lead to side effects such… February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024 Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic …are offered surgery, which prevents cancer but robs them of the chance to have children afterwards. At the same time, many other cases of ovarian cancer aren’t picked up until… December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 5 Feb 2018 New Antiviral for RSV Lung Infections Shows Promise in Phase IIa …the treatment of RSV infections. The candidate is a fusion inhibitor, which means it prevents the virus from replicating by blocking it from entering the host cell. This varies from… February 5, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 31 Mar 2023 How has the collapse of the Silicon Valley Bank affected the biotech industry? …– a move by the Federal Reserve to counteract rising inflation – panic followed a bank run. And in a swift spur of events, the collapse of the California-based bank… March 31, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jun 2023 AbbVie takes step forward in Europe with migraine drug …mg QD was well tolerated and the most common adverse events were constipation, nausea, and fatigue. The adverse drug reaction most commonly leading to study discontinuation was nausea (0.4%). “Far… June 26, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 …supports tumor growth and survival. Unlike other HER3-targeting therapies, HMBD-001 binds to a unique epitope on HER3, effectively locking the receptor in an inactive state. This prevents its activation by… November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2025 Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology …Cas nucleases, G-dase E is the first to demonstrate a substantial cytotoxic effect in targeted cells, caused by the degradation of the genome. Contrary to Cas9-based editing events, G-dase E… February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by BeOne Medicines 26 Jun 2025 How can treatment strategies evolve to address the challenges in chronic lymphocytic leukemia? …≥3 adverse events for zanubrutinib (greater than 10%) were neutropenia and hypertension. Driving what’s next While some patients find freedom in continuous treatment, others seek a different kind of freedom… June 26, 2025 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2022 DNA synthesis: tackling the main bottleneck in biology research …to cover most of the genetic space.” While these starter sequences come from providers that use chemical methods, the assembly is made using an enzymatic method that prevents the introduction… June 13, 2022 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2023 Korean researchers develop antimicrobial peptides discovery tool …microorganisms as a natural defense against infections. AMPs combat harmful bacteria via a nonspecific mechanism that prevents them from developing antimicrobial resistance. Despite these abilities, research on AMPs is being… February 23, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2017 This Gene Therapy for Hemophilia Can Reduce Bleeding by 70% …its candidate, SPK-9001, could restore 34% of factor IX activity after a year of follow-up. This resulted in a 97% reduction of annual bleeding events, from 11 to 0.4 per… December 19, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email